We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$62.2B
AUM Growth
+$5.88B
Cap. Flow
+$2.89B
Cap. Flow %
4.64%
Top 10 Hldgs %
50.57%
Holding
2,272
New
161
Increased
855
Reduced
884
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 4.57%
2 Financials 2.87%
3 Consumer Discretionary 1.79%
4 Communication Services 1.48%
5 Healthcare 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
2026
Alaunos Therapeutics
TCRT
$4.74M
$30K ﹤0.01%
182
-2
-1% -$440
TAST
2027
DELISTED
Carrols Restaurant Group, Inc.
TAST
$30K ﹤0.01%
10,030
URG
2028
Ur-Energy
URG
$485M
$29K ﹤0.01%
24,035
-1
-0% -$2
AQMS icon
2029
Aqua Metals
AQMS
$9.63M
$27K ﹤0.01%
+109
New +$38.4K
TLMD
2030
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$27K ﹤0.01%
+21,186
New +$42.5K
SLE icon
2031
Super League Enterprise
SLE
$4.28M
$24K ﹤0.01%
1
GALT icon
2032
Galectin Therapeutics
GALT
$229M
$23K ﹤0.01%
+11,048
New +$31.5K
GLDG
2033
GoldMining Inc
GLDG
$179M
$23K ﹤0.01%
18,942
+5,600
+42% +$7.27K
IDEX
2034
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$23K ﹤0.01%
154
PSTV icon
2035
Plus Therapeutics
PSTV
$26.4M
$22K ﹤0.01%
56
+7
+14% +$4.03K
BOXL icon
2036
Boxlight
BOXL
$2.37M
$21K ﹤0.01%
11
-2
-15% -$5.27K
SPPI
2037
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$21K ﹤0.01%
16,531
-1
-0% -$2
GSAT icon
2038
Globalstar
GSAT
$10.2B
$20K ﹤0.01%
+1,166
New +$25.6K
MUX icon
2039
McEwen Inc
MUX
$1.03B
$18K ﹤0.01%
1,977
NGD
2040
DELISTED
New Gold Inc
NGD
$18K ﹤0.01%
11,700
CIFRW
2041
DELISTED
Cipher Mining Warrant
CIFRW
$17K ﹤0.01%
15,000
+2,000
+15% +$3.94K
HELP
2042
Cybin Inc
HELP
$472M
$17K ﹤0.01%
374
-2
-0.5% -$127
ENVB icon
2043
Enveric Biosciences
ENVB
$5.2M
$16K ﹤0.01%
2
INM icon
2044
InMed Pharmaceuticals
INM
$9.13M
$14K ﹤0.01%
22
WATT icon
2045
Energous
WATT
$80.3M
$14K ﹤0.01%
19
NH
2046
DELISTED
NantHealth, Inc
NH
$14K ﹤0.01%
873
-5
-0.6% -$106
SDOT icon
2047
Sadot Group
SDOT
$18.5M
$13K ﹤0.01%
9
DMK
2048
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$13K ﹤0.01%
+314
New +$19.6K
VCNX
2049
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$11K ﹤0.01%
52
CFMS
2050
DELISTED
Conformis, Inc. Common Stock
CFMS
$11K ﹤0.01%
595

Similar funds

Creative Planning's Q4 2021 Portfolio in Review

As of Q4 2021, Creative Planning held 2,272 positions worth $62.2B, up 10% from $56.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Creative Planning deployed $2.89B of net new capital in Q4 2021, opening 161 new positions and adding to 855 existing holdings. Its largest new stake was TELUS International: 731,047 shares worth $24.2M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 4.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $78.3M trimmed.

  • Creative Planning's largest Q4 2021 buy was TELUS International: 731,047 shares worth $24.2M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2021, an estimated $440M increase.
  • Creative Planning's biggest Q4 2021 reduction was Vanguard Total Stock Market ETF, cutting an estimated $78.3M.
  • Creative Planning fully exited Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes in Q4 2021, selling an estimated $5.03M.
  • Creative Planning's ten largest holdings make up 51% of its $62.2B portfolio in Q4 2021.
  • Creative Planning opened 161 new positions and closed 199 in Q4 2021.
  • Creative Planning's portfolio value rose 10% quarter-over-quarter to $62.2B.

Based on Creative Planning's 13F filing for Q4 2021, filed 11 Feb 2022.